Satellos Bioscience MSLE
NASDAQ MSLE
$6.75 -0.45 (-6.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Satellos Bioscience (MSLE) Depreciation & Amortization (CF) (2025 - 2026)

Updated

Satellos Bioscience's Depreciation & Amortization (CF) came in at $1,000 for the quarter ended Jun 30, 2026, unchanged from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Satellos Bioscience reported Depreciation & Amortization (CF) of $3,000; for the year ended Dec 31, 2025, it was $4,000, down 73.3% from the prior year.

  • Going back by year, Depreciation & Amortization (CF) was $15,000 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Satellos Bioscience 109.60 Mn -98.54 Mn - 1,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Mar 31, 2026 1,000.00
Mar 31, 2025 1,000.00
API Access

Satellos Bioscience Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MSLE&period=max&api_key=YOUR_API_KEY